While patents may be the primary intellectual property concern in technology commercialization, trademark, trade secret, and copyright issues also arise in this context. The August 8 webinar will cover these important areas of intellectual property law.
Copyright protects original works of authorship. In scientific and engineering research, copyright may come into play when researchers publish journal articles relating to their research or use software protected by copyright. Businesses outside the copyright-based industries frequently overlook copyright as a means of protecting valuable business assets. Consideration should be given to protecting copyright in, for example, artwork in logos, product design, product packaging, product catalogues, websites, newsletters, promotional materials, and instruction manuals--the types of materials that are generated by all businesses.
A trademark is a word, phrase, symbol or design-- or a combination of any of these--that serves to identify and distinguish a specific product or service from others in the marketplace. Even colors, smells, sounds, and product shapes can be trademarks in some instances. As a part of the commercialization process, entrepreneurs need to choose and protect trademarks for their new ventures and products. Not all trademarks are created equal. There are significant differences in the types of marks that can function as trademarks and the extent to which they may be eligible for protection in any given country. Understanding these differences is essential to choosing a new trademark that can be protected in all relevant markets. The webinar will cover trademark selection, registration, and use.
A trade secret is business information that is not publicly known and brings economic benefits to the owner, for which the owner has adopted reasonable measures to maintain its confidentiality. Information such as customer and supplier lists, financial data, business plans, product formulas, manufacturing processes, marketing strategies, computer source code, and pricing information are often kept as trade secrets. An inventor may choose to protect technology as a trade secret rather than obtaining a patent. Trade secrets may be protected indefinitely so long as the information remains secret. If the secret is revealed, trade secret protection ceases. This webinar will discuss simple means for protection of trade secrets, the differences between patents and trade secrets, and trade secret misappropriation.
ABOUT THE WEBINAR SERIES:
The focus of this Webinar series is to help bridge the knowledge gap on Intellectual Property Law Issues between the US Government and various stakeholders in the “University-Based Startups Innovation Ecosystem”. A key attribute that make this webinar series unique from other programmatic endeavors is the ability to directly deliver “Thought Leaders” in the field who will address various IP issues from an applied, pragmatic, and deeply experienced viewpoint. Through participation in this webinar program, the audience will be afforded both the opportunity to understand and retain best practices when deriving appropriate IP-Strategic Frameworks coupled with Business and Technology Development, as well as gain access to a much more comprehensive and holistic viewpoint on why Intellectual Property Law is such an important economic tool in the “Entrepreneur’s Toolkit”.
ABOUT THE PRESENTERS:
Paul Rapp Intellectual Property Lawyer Adjunct Faculty, Albany Law School
Paul Rapp is an intellectual property lawyer and writer who lives and works in Housatonic, MA. Rapp teaches art & entertainment law at Albany Law School and MCLA, writes the column “Rapp on This” for Metroland, and appears regularly on WAMC’s VoxPop program as a copyright expert. Rapp is on the advisory boards of WAM Theatre and Shout Out Loud Productions and is president of the board of the Berkshire Community Radio Alliance. He’s also the drummer for the band Blotto.
Marina Lamm Patent Attornney, Office of Policy and External Affairs United States Patent and Trademark Office
Marina Lamm is a patent attorney with the Office of Policy and External Affairs, United States Patent and Trademark Office, specializing in intellectual property issues for Eastern Europe, Russia and the former Soviet Union. Ms. Lamm began her tenure at the USPTO as a Patent Examiner where she examined patent applications in chemical and pharmaceutical areas for over nine years.
Ms. Lamm is a graduate of the First Moscow Medical Institute, with a Bachelor of Science degree in Pharmacy, and the George Washington University, with a Master of Science degree in Forensic Science. Ms. Lamm received her law degree from the Catholic University of America Columbus School of Law. She is a member of the Maryland Bar and a registered patent attorney.
Scott Baldwin Attorney, Global Intellectual Property Academy (GIPA) United States Patent and Trademark Office
Scott Baldwin is an attorney in the Global Intellectual Property Academy(GIPA)at the United States Patent and Trademark Office (USPTO). Prior to this position, Scott served as a Trademark Attorney with the USPTO’s Office of Policy and External Affairs (OPEA) where he handled policy matters relating to trademark issues in the United States and abroad, and provided technical assistance to foreign governments that wanted to develop or improve their trademark systems. Scott was also a Trademark Examining Attorney at the USPTO for over nine years. Scott also worked as an attorney with the law firm of Fulbright & Jaworski in Washington, D.C.
ABOUT THE MODERATOR:
Ali Andalibi VP Research and CSO Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center former Program Director SBIR/STTR National Cancer Institute, NIH
Dr. Ali Andalibi is a Program Director and head of the Therapeutics and Diagnostics Cluster in the National Cancer Institute’s SBIR Development Center. Dr. Andalibi received his PhD from the UCLA department of Microbiology and Molecular Genetics and later joined the faculty in the UCLA department of Medicine. Subsequently, he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI) as Director of New Technology and Project Development and held a joint appointment in the Department of Otolaryngology at the University of Southern California, School of Medicine. Prior to moving to the NCI, Dr. Andalibi served as a Program Director in the National Science Foundation’s Division of Industrial Innovation and Partnerships, where he oversaw the NSF’s medical biotechnology SBIR/STTR grant portfolio.
VIEW PREVIOUS WEBINARS IN THIS SERIES:
To view video recordings and download presentation slides, please click on the links below.
All webinars listed below are scheduled from 1:00-2:30 pm ET. For changes in schedules and other announcements, please visit the series website.
September 12 – Researcher’s Life After Invention Disclosure Topics: Working with university TTOs, agreements, within the context of AIA
October 10 – Working with the USPTO: Selecting the Right Legal Advocates Topics: Working with the right TT Officer and law firm, addressing the documents needed for a proper application submission, drafting proper specification/drawings/claims, effective use of interview, understanding a final and non-final rejection
November 14: Patent Trial and Appeal Board & The Higher Courts Topics: Post-final rejection, post-grant review, appeal process, interpartes re-exam
December 12 – Protecting IP in Global Markets Understanding a PCT, international issues on IP procurement, markets and competitors
January 9, 2013 - Picking the Right Global Markets Topics: To where and how do I export? What programs are out there to help?
IMPORTANT INFORMATION FOR ATTENDEES:
WEBINAR SCHEDULE: This webinar series is scheduled every 2nd Wednesday of the month. Changes in schedules or topics will be posted on this page and sent to you through email.
WEBINAR DURATION: Each session is a 90-minute webinar with 60 minutes of presentation and 30 minutes of Q&A.
COST:Free, but registration required by clicking on the Register button above. Your registration is valid for all webinars in this series
HOW TO PARTICIPATE?: This webinar is online. You need a computer with web access for the visual/audio. You may also dial-in using the audio-only telephone number. The call in details and instructions on how to join the webinar will be sent to you via email after you register. Once registered to the webinar you will receive a reminder email 24 hours before the start of the webinar with instructions on how to join.
QUESTIONS TO SPEAKERS: Q&A is conducted by a chat box to the speakers.
WHO SHOULD PARTICIPATE IN THE WEBINAR?:National and international media, federal and state government officials, venture capitalists, angel investors, Global 1000 companies, industry representatives, university officials, entrepreneurs, tech transfer professionals, students, and university faculty and staff.
SLIDES AND VIDEO: The slide presentations and video recording will be available on this page. If you are unable to join the live webinar, you may view the recorded video that will be posted within 24 hours after the scheduled webinar ends.
For questions or more information, please email us at